Ahmed ElShafei1, Yaw Nyame2, Onder Kara2, Atef Badawy3, Ifeanyi Amujiogu2, Khaled Fareed2, Eric Klein2, J Stephen Jones4. 1. Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio; Urology Department, Al Kasr Al Aini Hospital, Cairo University, Giza, Egypt. 2. Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio. 3. Urology Department, Faculty of Medicine, Menofiya University, Menofiya, Egypt. 4. Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio. Electronic address: joness7@ccf.org.
Abstract
PURPOSE: We assessed the pathological outcomes after radical prostatectomy in men with favorable risk prostate cancer diagnosed on first/initial biopsy compared to those of men who were diagnosed on a subsequent/repeat prostate biopsy. MATERIALS AND METHODS: We identified 422 patients who met National Comprehensive Cancer Network® very low (199) and low risk (223) prostate cancer definitions who instead underwent radical prostatectomy. In each risk category we compared adverse pathological outcomes, defined as Gleason score upgrading, extraprostatic extension, seminal vesicle invasion and positive surgical margins, between men diagnosed on initial prostate biopsy vs repeat/subsequent prostate biopsy after a negative biopsy(-ies). RESULTS: There were no significant differences in the baseline clinical and demographic characteristics between the groups. However, men who were diagnosed on initial prostate biopsy demonstrated a higher median maximum cancer percent per single core (p <0.001) and higher median percent of positive cores (p <0.001). Compared to repeat/subsequent prostate biopsy, men diagnosed on initial prostate biopsy had a higher Gleason score upgrade (7 or greater) (57.7% vs 42.1%, p=0.005) and extraprostatic extension (14.1% vs 5.4%, p=0.01). On stratified analysis comparing initial prostate biopsy to repeat/subsequent prostate biopsy, very low risk disease was associated with Gleason score upgrade (49.3% vs 31.8%, p=0.02) and low risk disease demonstrated higher rates of extraprostatic extension (19.9% vs 6.0%, p=0.02). CONCLUSIONS: The likelihood of adverse pathological outcomes at radical prostatectomy is lower in men diagnosed with favorable risk prostate cancer on repeat/subsequent prostate biopsy than in men diagnosed on initial prostate biopsy, and may represent an important consideration in risk stratifying cases of favorable risk prostate cancer.
PURPOSE: We assessed the pathological outcomes after radical prostatectomy in men with favorable risk prostate cancer diagnosed on first/initial biopsy compared to those of men who were diagnosed on a subsequent/repeat prostate biopsy. MATERIALS AND METHODS: We identified 422 patients who met National Comprehensive Cancer Network® very low (199) and low risk (223) prostate cancer definitions who instead underwent radical prostatectomy. In each risk category we compared adverse pathological outcomes, defined as Gleason score upgrading, extraprostatic extension, seminal vesicle invasion and positive surgical margins, between men diagnosed on initial prostate biopsy vs repeat/subsequent prostate biopsy after a negative biopsy(-ies). RESULTS: There were no significant differences in the baseline clinical and demographic characteristics between the groups. However, men who were diagnosed on initial prostate biopsy demonstrated a higher median maximum cancer percent per single core (p <0.001) and higher median percent of positive cores (p <0.001). Compared to repeat/subsequent prostate biopsy, men diagnosed on initial prostate biopsy had a higher Gleason score upgrade (7 or greater) (57.7% vs 42.1%, p=0.005) and extraprostatic extension (14.1% vs 5.4%, p=0.01). On stratified analysis comparing initial prostate biopsy to repeat/subsequent prostate biopsy, very low risk disease was associated with Gleason score upgrade (49.3% vs 31.8%, p=0.02) and low risk disease demonstrated higher rates of extraprostatic extension (19.9% vs 6.0%, p=0.02). CONCLUSIONS: The likelihood of adverse pathological outcomes at radical prostatectomy is lower in men diagnosed with favorable risk prostate cancer on repeat/subsequent prostate biopsy than in men diagnosed on initial prostate biopsy, and may represent an important consideration in risk stratifying cases of favorable risk prostate cancer.
Authors: James T Kearns; Anna V Faino; Lisa F Newcomb; James D Brooks; Peter R Carroll; Atreya Dash; William J Ellis; Michael Fabrizio; Martin E Gleave; Todd M Morgan; Peter S Nelson; Ian M Thompson; Andrew A Wagner; Yingye Zheng; Daniel W Lin Journal: Eur Urol Date: 2018-02-09 Impact factor: 20.096
Authors: Mattia Luca Piccinelli; Stefano Luzzago; Giulia Marvaso; Ekaterina Laukhtina; Noriyoshi Miura; Victor M Schuettfort; Keiichiro Mori; Alberto Colombo; Matteo Ferro; Francesco A Mistretta; Nicola Fusco; Giuseppe Petralia; Barbara A Jereczek-Fossa; Shahrokh F Shariat; Pierre I Karakiewicz; Ottavio de Cobelli; Gennaro Musi Journal: World J Urol Date: 2022-03-26 Impact factor: 3.661
Authors: Jeffrey J Tosoian; Bruce J Trock; Todd M Morgan; Simpa S Salami; Scott A Tomlins; Daniel E Spratt; Javed Siddiqui; Lakshmi P Kunju; Rachel Botbyl; Zoey Chopra; Balaji Pandian; Nicholas W Eyrich; Gary Longton; Yingye Zheng; Ganesh S Palapattu; John T Wei; Yashar S Niknafs; Arul M Chinnaiyan Journal: J Urol Date: 2020-10-20 Impact factor: 7.450